Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Angiotensin Receptor Blockers ARBs Market Report 2024

Angiotensin Receptor Blockers (ARBs) Global Market Report 2025 – By Product (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan), By Application (Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers ) – Market Size, Trends, And Global Forecast 2025-2034

Angiotensin Receptor Blockers (ARBs) Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Angiotensin Receptor Blockers (ARBs) Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Angiotensin Receptor Blockers (ARBs) Market Definition

Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder.

The main products of angiotensin receptor blockers (ARBs) include valsartan, losartan, irbesartan, azilsartan and olmesartan. Losartan is an angiotensin receptor blocker that lowers the risk of stroke while treating hypertension and diabetic nephropathy. Their various applications include hypertension, cardiovascular diseases, kidney diseases, and others for use by end-users such as hospitals, specialty clinics, and ambulatory surgical centers.

Angiotensin Receptor Blockers (ARBs) Market Segmentation

The angiotensin receptor blockers (ARBs) market covered in this report is segmented –

1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Valsartan: Tablets, Capsules, Injectable Forms

2) By Telmisartan: Tablets, Capsules

3) By Losartan: Tablets, Oral Solution

4) By Irbesartan: Tablets, Oral Solution

5) By Azilsartan: Tablets

6) By Olmesartan: Tablets, Oral Suspension

Angiotensin Receptor Blockers (ARBs) Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

Angiotensin Receptor Blockers (ARBs) Market Size 2025 And Growth Rate

The angiotensin receptor blockers (ARBs) market size has grown steadily in recent years. It will grow from $8.51 billion in 2024 to $8.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, ARBs as first-line treatment, cost-effectiveness.

Angiotensin Receptor Blockers (ARBs) Market Growth Forecast

The angiotensin receptor blockers (ARBs) market size is expected to see steady growth in the next few years. It will grow to $10.76 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension. Major trends in the forecast period include telemedicine adoption, research and development investments, generic competition and patent expirations, digital health solutions for medication adherence, biosimilar competition.

Book your 30 minutes free consultation with our research experts

Contact Us

Angiotensin Receptor Blockers (ARBs) Market Driver: Rising Cardiovascular Disease Incidence Sparks Surge In Angiotensin Receptor Blockers Market

The increasing incidence of cardiovascular diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Cardiovascular disease (CVD) is any condition affecting the heart or blood vessels. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. Angiotensin receptor blockers lower blood pressure and improve the heart's capacity to pump blood by helping in vein and artery relaxation, which can minimize the risk of cardiovascular disease. For instance, in August 2022, according to the American College of Cardiology, a US-based professional medical organization, the expected rates of cardiovascular risk factors and disease will considerably rise in the United States by the year 2060. Therefore, the increasing incidence of cardiovascular diseases is driving the growth of the angiotensin receptor blockers market.

Angiotensin Receptor Blockers (ARBs) Market Driver: Rising Chronic Kidney Disease Rates Drive Surge In Angiotensin Receptor Blockers Market

The increasing chronic kidney diseases is expected to propel the growth of the angiotensin receptor blockers market going forward. Chronic kidney disease (CKD) is a long-term condition characterized by the gradual loss of kidney function over time. Angiotensin receptor blockers (ARBs) are used in the management of chronic kidney diseases (CKD) by lowering blood pressure, provide renal protection, to manage diabetic nephropathy, and in cardiovascular complications. For instance, in June 2023, according to the University of Oxford, a UK-based higher education institution, from 2022 to 2032, the prevalence of CKD is expected to increase by 4% from 8.27 million to 8.61 million people in the UK. Therefore, the increasing chronic kidney diseases are driving the growth of the angiotensin receptor blockers market.

Angiotensin Receptor Blockers (ARBs) Market Driver: Rising Hypertension Rates Propel Growth In Angiotensin Receptor Blockers (ARBs) Market

The increase in the prevalence of hypertension diseases is expected to propel the growth of the angiotensin receptor blockers (ARBs) market going forward. Hypertension, often known as high or rising blood pressure, is a disorder characterized by chronically elevated blood vessel pressure. Angiotensin receptor blockers (ARBs) are a type of medication that is commonly used to treat hypertension. They primarily function by relaxing and widening the blood arteries, giving the blood greater room to pass through. Thus, increasing hypertension diseases among people will increase the demand for angiotensin receptor blockers. For instance, in March 2023, the World Health Organization, a Switzerland-based intergovernmental organization published that approximately 1.28 billion adults aged 30 to 79 globally have hypertension, with the majority (two-thirds) residing in low- and middle-income countries. It is estimated that 46% of adults with hypertension are unaware of their condition. Also, in December 2023, according to The Australian Bureau of Statistics, an Australia-based government agency published that in 2022, more than one in ten individuals (11.6% or 3.0 million) reported having hypertension. Therefore, the increase in the prevalence of hypertension diseases is driving the growth of the angiotensin receptor blockers (ARBs) market.

Global Angiotensin Receptor Blockers (ARBs) Market Major Players

Major companies operating in the angiotensin receptor blockers (ARBs) market include Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma

Global Angiotensin Receptor Blockers (ARBs) Market Trend: Innovative Product Solution In The Angiotensin Receptor Blockers Market

Major companies in the angiotensin receptor blocker market are developing advanced products, such as angiotensin receptor neprilysin inhibitors, to enhance treatment options and improve outcomes for patients with cardiovascular conditions. Angiotensin receptor neprilysin inhibitors (ARNIs) are a class of medications used to treat heart failure. For instance, In January 2023, Glenmark Pharmaceuticals, an India-based pharmaceutical company, launched sacubitril + valsartan tablets, which specialize in the treatment of heart failure, specifically targeting heart failure with reduced ejection fraction (HFrEF). This combination falls under the class of medications known as ARNI (angiotensin receptor neprilysin inhibitors). Sacubitril enhances the natriuretic peptide (NP) system, which alleviates fluid overload and promotes blood vessel dilation, while valsartan blocks the renin-angiotensin system (RAS) to lower blood pressure and lessens the heart's workload. Together, they effectively improve heart failure symptoms, reduce the risk of cardiovascular mortality, and decrease the chances of hospitalization due to heart failure. They are marketed under the brand name Sacu V.

Global Angiotensin Receptor Blockers (ARBs) Market Trend: Advancements in Angiotensin Receptor Blockers (ARBs) for Hypertension Treatment

Major market players in the angiotensin receptor blockers (ARBs) market are developing advanced products, such as prescription medications, to enhance the treatment of conditions like hypertension and heart failure and improve patient outcomes. Prescription medication refers to drugs that are legally dispensed to patients only when prescribed by a licensed healthcare professional, such as a doctor, nurse practitioner, or dentist. For instance, in July 2022, Lupin, an India-based transnational pharmaceutical company received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health of Azilsartan Medoxomil Tablets. Azilsartan Medoxomil Tablets is a prescription medication used primarily for the treatment of hypertension (high blood pressure). They provide an effective treatment option for hypertension, helping to lower blood pressure and reduce the risk of cardiovascular events. They belong to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels, allowing blood to flow more easily, and thereby helping to lower blood pressure. Lowering blood pressure helps prevent strokes, heart attacks, and kidney problems.

Regional Analysis For The Global Angiotensin Receptor Blockers (ARBs) Market

North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in the angiotensin receptor blockers (ARBs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the angiotensin receptor blockers (ARBs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angiotensin Receptor Blockers (ARBs) Market?

The angiotensin receptor blockers (ARBs) market consists of sales of candesartan and eprosartan. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Angiotensin Receptor Blockers (ARBs) Industry?

The angiotensin receptor blockers (ARBs) market research report is one of a series of new reports from The Business Research Company that provides angiotensin receptor blockers (ARBs) market statistics, including angiotensin receptor blockers (ARBs) industry global market size, regional shares, competitors with a angiotensin receptor blockers (ARBs) market share, detailed angiotensin receptor blockers (ARBs) market segments, market trends and opportunities, and any further data you may need to thrive in the angiotensin receptor blockers (ARBs) industry. This angiotensin receptor blockers (ARBs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Angiotensin Receptor Blockers (ARBs) Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $8.87 billion
Revenue Forecast In 2034 $10.76 billion
Growth Rate CAGR of 5.0% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Subsegments: 1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets 6) By Olmesartan: Tablets, Oral Suspension
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific, Sanofi, Johnson & Johnson, Eli Lilly, Bayer AG, Abbvie Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Zydus Cadila, Glenmark Pharmaceuticals Ltd., Cipla Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zhejiang Huahai Pharmaceutical Co. Ltd., Boehringer Ingelheim Ltd., Astellas Pharma
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Angiotensin Receptor Blockers (ARBs) Market Characteristics

    3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies

    4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

    5. Global Angiotensin Receptor Blockers (ARBs) Growth Analysis And Strategic Analysis Framework

    5.1. Global Angiotensin Receptor Blockers (ARBs) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Angiotensin Receptor Blockers (ARBs) Market Growth Rate Analysis

    5.4. Global Angiotensin Receptor Blockers (ARBs) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Angiotensin Receptor Blockers (ARBs) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Angiotensin Receptor Blockers (ARBs) Total Addressable Market (TAM)

    6. Angiotensin Receptor Blockers (ARBs) Market Segmentation

    6.1. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Valsartan

    Telmisartan

    Losartan

    Irbesartan

    Azilsartan

    Olmesartan

    6.2. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hypertension

    Cardiovascular Diseases

    Kidney Diseases

    Other Applications

    6.3. Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Hospitals

    Specialty Clinics

    Ambulatory Surgical Centers

    6.4. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    Capsules

    Injectable Forms

    6.5. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    Capsules

    6.6. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    Oral Solution

    6.7. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    Oral Solution

    6.8. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    6.9. Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Tablets

    Oral Suspension

    7. Angiotensin Receptor Blockers (ARBs) Market Regional And Country Analysis

    7.1. Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market

    8.1. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.4. Asia-Pacific Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Angiotensin Receptor Blockers (ARBs) Market

    9.1. China Angiotensin Receptor Blockers (ARBs) Market Overview

    9.2. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.4. China Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Angiotensin Receptor Blockers (ARBs) Market

    10.1. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.3. India Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Angiotensin Receptor Blockers (ARBs) Market

    11.1. Japan Angiotensin Receptor Blockers (ARBs) Market Overview

    11.2. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.4. Japan Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Angiotensin Receptor Blockers (ARBs) Market

    12.1. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.3. Australia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Angiotensin Receptor Blockers (ARBs) Market

    13.1. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.3. Indonesia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Angiotensin Receptor Blockers (ARBs) Market

    14.1. South Korea Angiotensin Receptor Blockers (ARBs) Market Overview

    14.2. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.4. South Korea Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Angiotensin Receptor Blockers (ARBs) Market

    15.1. Western Europe Angiotensin Receptor Blockers (ARBs) Market Overview

    15.2. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.4. Western Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Angiotensin Receptor Blockers (ARBs) Market

    16.1. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.3. UK Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Angiotensin Receptor Blockers (ARBs) Market

    17.1. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.3. Germany Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Angiotensin Receptor Blockers (ARBs) Market

    18.1. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.3. France Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Angiotensin Receptor Blockers (ARBs) Market

    19.1. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.3. Italy Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Angiotensin Receptor Blockers (ARBs) Market

    20.1. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.3. Spain Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market

    21.1. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market Overview

    21.2. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.4. Eastern Europe Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Angiotensin Receptor Blockers (ARBs) Market

    22.1. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.3. Russia Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Angiotensin Receptor Blockers (ARBs) Market

    23.1. North America Angiotensin Receptor Blockers (ARBs) Market Overview

    23.2. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.4. North America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Angiotensin Receptor Blockers (ARBs) Market

    24.1. USA Angiotensin Receptor Blockers (ARBs) Market Overview

    24.2. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.4. USA Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Angiotensin Receptor Blockers (ARBs) Market

    25.1. Canada Angiotensin Receptor Blockers (ARBs) Market Overview

    25.2. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.4. Canada Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Angiotensin Receptor Blockers (ARBs) Market

    26.1. South America Angiotensin Receptor Blockers (ARBs) Market Overview

    26.2. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.4. South America Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Angiotensin Receptor Blockers (ARBs) Market

    27.1. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.3. Brazil Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Angiotensin Receptor Blockers (ARBs) Market

    28.1. Middle East Angiotensin Receptor Blockers (ARBs) Market Overview

    28.2. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.4. Middle East Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Angiotensin Receptor Blockers (ARBs) Market

    29.1. Africa Angiotensin Receptor Blockers (ARBs) Market Overview

    29.2. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.4. Africa Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Company Profiles

    30.1. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape

    30.2. Angiotensin Receptor Blockers (ARBs) Market Company Profiles

    30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

    31. Angiotensin Receptor Blockers (ARBs) Market Other Major And Innovative Companies

    31.1. GlaxoSmithKline plc

    31.2. Teva Pharmaceutical Industries Ltd.

    31.3. Daiichi Sankyo Company Limited

    31.4. Lupin Limited

    31.5. Dr. Reddy’s Laboratories Ltd.

    31.6. Takeda Pharmaceutical Company Limited

    31.7. Thermo Fisher Scientific

    31.8. Sanofi

    31.9. Johnson & Johnson

    31.10. Eli Lilly

    31.11. Bayer AG

    31.12. Abbvie Inc.

    31.13. Mylan N.V.

    31.14. Sun Pharmaceutical Industries Ltd.

    31.15. Torrent Pharmaceuticals Ltd.

    32. Global Angiotensin Receptor Blockers (ARBs) Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market

    34. Recent Developments In The Angiotensin Receptor Blockers (ARBs) Market

    35. Angiotensin Receptor Blockers (ARBs) Market High Potential Countries, Segments and Strategies

    35.1 Angiotensin Receptor Blockers (ARBs) Market In 2029 - Countries Offering Most New Opportunities

    35.2 Angiotensin Receptor Blockers (ARBs) Market In 2029 - Segments Offering Most New Opportunities

    35.3 Angiotensin Receptor Blockers (ARBs) Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Pfizer Inc. Financial Performance
  • Table 81: Novartis AG Financial Performance
  • Table 82: Merck & Co. Inc. Financial Performance
  • Table 83: AstraZeneca Plc. Financial Performance
  • Table 84: Bristol-Myers Squibb Company Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Valsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Telmisartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Losartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Irbesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Azilsartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Angiotensin Receptor Blockers (ARBs) Market, Sub-Segmentation Of Olmesartan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Angiotensin Receptor Blockers (ARBs) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Angiotensin Receptor Blockers (ARBs) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Pfizer Inc. Financial Performance
  • Figure 81: Novartis AG Financial Performance
  • Figure 82: Merck & Co. Inc. Financial Performance
  • Figure 83: AstraZeneca Plc. Financial Performance
  • Figure 84: Bristol-Myers Squibb Company Financial Performance

Latest Cell Therapy Market Growth Study 2022-2026 By The Business Research Company

Read More

Global Gene Therapy Market 2022 – Market Opportunities And Strategies

Read More

The Microbiome Market Share, Market Size, And Growth Rate 2022

Read More

The Plasma Fractionation Market Share, Market Size, And Growth Rate 2022

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the plasma fractionation market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the CNS drugs market research report 2022 with industry size, share, segments and market growth

Read More

The Business Research Company offers the nucleic acid based gene therapy market research report 2022 with industry size, share, segments and market growth

Read More

Blood And Blood Components Global Market Report 2025 – By Product (Whole Blood, Blood Components), By Blood Components (Red Blood Cells, Platelets, Plasma, White Blood Cells), By End-User (Hospitals, Ambulatory Surgical Centers, Others), By Application (Anemia, Trauma and Surgery, Cancer Treatment, Bleeding Disorders) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Convalescent Plasma Therapy Global Market Report 2025 – By Antibody type (IgM, IgG, IgA), By Application (Prophylaxis, Treatment), By End-Users (Hospitals & Clinics, Laboratories & Research institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Patient Blood Management Global Market Report 2025 – By Product (Instruments, Accessories, Reagents And Kits, Software), By Component (Plasma, Whole Blood, Red Blood Cells), By Application (Hospital, Clinic, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Plasma Therapy Global Market Report 2025 – By Type (Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)), By Application (Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications), By End-Users (Hospitals & Clinics, Laboratories (Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Mycoplasma Testing Global Market Report 2025 – By Product (Instruments, Assay, Kits, and Reagents), By Technology (PCR, ELISA, Enzymatic Methods, DNA Staining, Other Technologies), By Application (Cell line Testing, Virus Testing, End- of- Production Cell Testing), By End User (Pharmaceutical & Biotechnology Companies, Cell Banks & Laboratories, Contract Research Organizations, Academic Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cold Plasma Global Market Report 2025 – By Regime (Atmospheric Cold Plasma, Low-Pressure Cold Plasma ), By Technology (Remote Treatment, Direct Treatment, Electrode Contact ), By Application (Wound Healing, Blood Coagulation, Dentistry, Cancer Treatment, Other Medical Applications), By End Use Sector (Automotive, Electronics & Semiconductors, Food Processing & Packaging, Medical, Aerospace, Polymers & Plastics, Other End-User Sector) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Porcine Plasma Feed Global Market Report 2025 – By Type (Powder, Grain, Other Types), By Application (Swine Feed, Pet Food, Aquafeed, Other Applications), By End User (Farmers, Farming Organizations, Feed Additive Companies, Animal Feed For Pets) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Blood Transfusion Diagnostics Global Market Report 2025 – By Type (Instruments and Kits, Reagents, Other Types), By Technology (Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence assay, Rapid Test), By Application (Blood Grouping, Disease Screening), By End User (Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the angiotensin receptor blockers (ARBs) market?

Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder. For further insights on the angiotensin receptor blockers (ARBs) market, request a sample here

How will the angiotensin receptor blockers (ARBs) market drivers and restraints affect the angiotensin receptor blockers (ARBs) market dynamics? What forces will shape the angiotensin receptor blockers (ARBs) industry going forward?

The angiotensin receptor blockers (ARBs) market major growth driver - Angiotensin receptor blockers (ARBs) are medications that dilate (widen) blood vessels and are used to treat conditions such as high blood pressure (hypertension), heart failure, and kidney disease in people with diabetes. Angiotensin is a chemical in the body that causes blood vessels to constrict. This constriction can raise the blood pressure and make the heart work harder.. For further insights on the angiotensin receptor blockers (ARBs) market, request a sample here

What is the forecast market size or the forecast market value of the angiotensin receptor blockers (ARBs) market?

The angiotensin receptor blockers (ARBs) market size has grown steadily in recent years. It will grow from $8.51 billion in 2024 to $8.87 billion in 2025 at a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be attributed to hypertension epidemic, clinical efficacy, cardiovascular disease burden, renal protection, clinical guidelines, ARBs as first-line treatment, cost-effectiveness. The angiotensin receptor blockers (ARBs) market size is expected to see steady growth in the next few years. It will grow to $10.76 billion in 2029 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to precision medicine approaches, focus on combination therapies, global expansion of market, biomarker-based treatment strategies, government initiatives, increased awareness of hypertension. Major trends in the forecast period include telemedicine adoption, research and development investments, generic competition and patent expirations, digital health solutions for medication adherence, biosimilar competition. For further insights on the angiotensin receptor blockers (ARBs) market, request a sample here

How is the angiotensin receptor blockers (ARBs) market segmented?

The angiotensin receptor blockers (ARBs) market is segmented
1) By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
2) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers Subsegments:
1) By Valsartan: Tablets, Capsules, Injectable Forms
2) By Telmisartan: Tablets, Capsules
3) By Losartan: Tablets, Oral Solution
4) By Irbesartan: Tablets, Oral Solution
5) By Azilsartan: Tablets
6) By Olmesartan: Tablets, Oral SuspensionFor further insights on the angiotensin receptor blockers (ARBs) market, request a sample here

Which region has the largest share of the angiotensin receptor blockers (ARBs) market? What are the other regions covered in the report?

North America was the largest region in the angiotensin receptor blockers (ARBs) market share in 2024. The regions covered in the angiotensin receptor blockers (ARBs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the angiotensin receptor blockers (ARBs) market, request a sample here.

Who are the major players in the angiotensin receptor blockers (ARBs) market?

Major market players in the angiotensin receptor blockers (ARBs) market are developing advanced products, such as prescription medications, to enhance the treatment of conditions like hypertension and heart failure and improve patient outcomes. Prescription medication refers to drugs that are legally dispensed to patients only when prescribed by a licensed healthcare professional, such as a doctor, nurse practitioner, or dentist. For instance, in July 2022, Lupin, an India-based transnational pharmaceutical company received approval from the Food and Drug Administration (FDA), a US-based federal agency for protecting the public health of Azilsartan Medoxomil Tablets. Azilsartan Medoxomil Tablets is a prescription medication used primarily for the treatment of hypertension (high blood pressure). They provide an effective treatment option for hypertension, helping to lower blood pressure and reduce the risk of cardiovascular events. They belong to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels, allowing blood to flow more easily, and thereby helping to lower blood pressure. Lowering blood pressure helps prevent strokes, heart attacks, and kidney problems. For further insights on the angiotensin receptor blockers (ARBs) market, request a sample here.

What are the key trends in the angiotensin receptor blockers (ARBs) market?

Major trend in the angiotensin receptor blockers (ARBs) market - Innovative Product Solution In The Angiotensin Receptor Blockers Market. For further insights on the angiotensin receptor blockers (ARBs) market, request a sample here.

What are the major opportunities in the angiotensin receptor blockers (ARBs) market? What are the strategies for the angiotensin receptor blockers (ARBs) market?

For detailed insights on the major opportunities and strategies in the angiotensin receptor blockers (ARBs) market, request a sample here.

How does the angiotensin receptor blockers (ARBs) market relate to the overall economy and other similar markets?

For detailed insights on angiotensin receptor blockers (ARBs) market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the angiotensin receptor blockers (ARBs) industry?

For detailed insights on the mergers and acquisitions in the angiotensin receptor blockers (ARBs) industry, request a sample here.

What are the key dynamics influencing the angiotensin receptor blockers (ARBs) market growth? SWOT analysis of the angiotensin receptor blockers (ARBs) market.

For detailed insights on the key dynamics influencing the angiotensin receptor blockers (ARBs) market growth and SWOT analysis of the angiotensin receptor blockers (ARBs) industry, request a sample here.